Ares Closes $9.8B Credit Fund as Distressed Debt Bets Heat Up

Ares Management closed its fifth opportunistic credit fund at $9.8 billion, the firm announced Monday, marking one of the largest distressed debt vehicles raised as corporate America stares down a refinancing crunch. The fund — Ares Pathfinder Fund V — pulled in 63% more capital than its predecessor and positions the Los Angeles-based credit giant to capitalize on mounting stress in leveraged loan and high-yield bond markets.

The raise comes as more than $800 billion in leveraged loans and high-yield bonds are set to mature through 2028, according to LCD data, with a significant portion sitting in the hands of borrowers who loaded up on cheap debt during the zero-rate era. Those companies now face a brutal choice: refinance at rates 400-500 basis points higher than their original terms, or negotiate with lenders from a position of weakness.

Ares isn't alone in smelling opportunity. Apollo Global Management raised $6.5 billion for its latest opportunistic credit strategy last year, while Oaktree Capital Management closed a $11.9 billion distressed debt fund in 2024. But Ares' fund represents one of the few vehicles purpose-built to move fluidly between distressed debt, stressed loans, and structured credit — a flexibility that could prove critical as market dislocations unfold unevenly across sectors.

"We're not calling this a distressed cycle — we're calling it an opportunistic environment," said Michael Arougheti, Ares' co-founder and CEO, in a statement. "The companies in trouble aren't always obvious, and the pricing dislocations aren't always where you'd expect them."

Limited partners poured capital into the fund despite the strategy's uneven track record over the past decade. The reason? They've watched distressed specialists sit on dry powder for years, waiting for defaults that never materialized — and they don't want to miss the entry window this time.

Default rates in U.S. leveraged loans hit 4.2% in Q4 2025, up from 1.8% a year earlier, per Moody's. That's still below the 10-year average of 4.8%, but the trajectory matters more than the headline number. Distressed exchanges — where borrowers restructure debt outside of bankruptcy — jumped 140% year-over-year, signaling that stress is accelerating even if formal defaults haven't spiked yet.

And crucially, the Federal Reserve's recent pause on rate cuts means borrowing costs aren't coming down anytime soon. Companies that bet on a swift return to sub-4% rates are now scrambling to extend maturities or sell assets. That creates the exact conditions distressed investors hunt for: forced sellers, mispriced assets, and capital scarcity.

Ares' fund attracted a mix of sovereign wealth funds, public pensions, and insurance companies, according to people familiar with the raise. The firm declined to disclose individual LPs, but confirmed that 68% of commitments came from existing investors — a sign that prior funds delivered returns strong enough to warrant repeat allocations.

The fund's mandate spans four asset classes: distressed corporate debt, stressed performing loans, non-performing loans, and structured credit. That breadth gives Ares room to shift capital as opportunities emerge, but it also means the fund won't be confined to classic Chapter 11 situations.

The firm has already deployed roughly $1.2 billion from the fund into 14 positions, according to regulatory filings reviewed by this publication. Those investments skew toward senior secured loans in companies with enterprise values between $500 million and $3 billion — the messy middle of the market where pricing inefficiencies persist because fewer institutional buyers compete.

One early deal: a $180 million stake in the first-lien term loan of a regional healthcare services company that missed a debt payment in January. Ares bought the loan at 72 cents on the dollar, then led a consent solicitation that extended the maturity by 18 months in exchange for a 200-basis-point fee and warrants for 8% of the equity. The company avoided bankruptcy, Ares locked in mid-teens returns, and existing lenders took a haircut.

That deal structure — extend-and-pretend with a kicker — has become Ares' signature move. The firm avoids protracted bankruptcy litigation when possible, preferring to negotiate consensual restructurings that preserve relationships and accelerate exits. It's a strategy that works best in situations where the underlying business is viable but the capital structure isn't.

Ares is concentrating firepower on three sectors: commercial real estate debt, software companies that over-levered during the ZIRP era, and industrial businesses exposed to supply chain reconfiguration. Each has distinct stress drivers, but all share a common trait: assets worth defending, capital structures worth attacking.

Pathfinder V carries two structural changes that distinguish it from the 2023 vintage. First, the fund has a longer deployment period — five years instead of four — giving Ares room to wait for deeper dislocations rather than rushing capital out the door. Second, the fund can allocate up to 30% of commitments to structured credit and CLO equity, up from 20% in the prior fund.

That second change matters more than it sounds. CLO equity and junior tranches of structured credit have been repricing aggressively as base rates stay elevated. Yields on BB-rated CLO tranches are hovering around 11-13%, and equity returns are tracking in the high teens — well above the cost of capital for most institutional investors. Ares can now lean harder into that opportunity set without breaching concentration limits.

The fund also operates with a hard cap on single-name exposure: no more than 5% of committed capital can go into any one credit. That's tighter than the 7.5% limit in Pathfinder IV, a reflection of LP demands for greater diversification after several high-profile restructurings dragged on longer than expected.

One notable example: Ares' investment in the debt of Envision Healthcare, which entered bankruptcy in 2023 and didn't emerge until mid-2025. The firm ultimately posted a 9% IRR on the position — respectable but below the fund's 15% net return target. LPs wanted assurances that concentrated bets wouldn't dilute overall performance, and the tighter exposure limits are Ares' answer.

Performance on Pathfinder IV, which is roughly 70% deployed, has been strong enough to justify the larger raise. The fund is tracking to a 14.2% net IRR through Q4 2025, per an investor letter reviewed by this publication, with realized investments averaging 18% returns and a handful of write-downs pulling the blended figure lower.

Ares structured the fund with a 1.5% management fee and a 20% carry with an 8% preferred return — a step down from the 1.75%/20%/7% terms on Pathfinder IV. The fee compression reflects LP pushback on private credit economics broadly, but also Ares' willingness to trade margin for scale. At $9.8 billion, even a 1.5% management fee generates $147 million in annual revenue before deployment costs.

The firm didn't offer a founder's share or discounted fees for early closers, which had been standard on prior funds. That signals confidence in the strategy's appeal — and perhaps a recognition that LPs have more negotiating leverage in a crowded fundraising market.

Ares enters the market alongside a wave of distressed-focused funds that have collectively raised more than $40 billion since early 2024. That's the largest two-year fundraising cycle for the strategy since 2008-2009, when the global financial crisis triggered a flood of capital into distressed debt vehicles.

Oaktree's $11.9 billion Opportunities Fund XII remains the largest in the current cycle, but it's also the broadest in scope — investing across public and private markets, real estate, and corporate debt. Apollo's $6.5 billion fund focuses more narrowly on performing credit with embedded distress optionality, while Centerbridge Partners is reportedly in the market for a $5 billion vehicle targeting liability management transactions.

Smaller specialists are also raising. King Street Capital closed a $2.1 billion fund in December, and Marathon Asset Management is targeting $3 billion for a vehicle focused exclusively on non-performing loans. The proliferation of strategies reflects both LP enthusiasm and uncertainty about where distress will show up first — and most profitably.

The risk, of course, is overcapitalization. If $40 billion-plus in dry powder chases a finite pool of distressed assets, returns compress and bidding wars emerge. That's what happened in 2016-2018, when distressed funds raised aggressively but defaults never spiked, leaving many vehicles stuck in low-returning performing credit.

The bull case for distressed debt is straightforward: rates are structurally higher, leverage is structurally elevated, and a refinancing wave is structurally unavoidable. But the bear case is harder to dismiss than it was in prior cycles.

Corporate balance sheets are stronger than they were heading into 2008. Cash balances are elevated, and most companies termed out their debt during the 2020-2021 refinancing boom. The companies most at risk — overleveraged sponsors-backed businesses in discretionary sectors — represent a smaller slice of the market than they did pre-GFC.

What's different this time is the *type* of stress. It's not a liquidity crisis or a demand shock — it's a slow-motion margin squeeze driven by higher input costs, wage inflation, and interest expenses that didn't exist three years ago. That kind of stress takes longer to resolve and produces fewer clean bankruptcies. Instead, it generates liability management exercises, uptier exchanges, and contested restructurings — all of which require more legal firepower and patience than traditional distressed plays.

Ares is well-positioned for that environment. The firm has 180 investment professionals dedicated to credit, including 40 focused exclusively on special situations and restructurings. That's more bodies than most competitors can deploy, and it allows Ares to pursue complex, labor-intensive deals that smaller funds avoid.

The most uncomfortable question for distressed investors: what if this isn't 2008, or even 2001? What if defaults tick up modestly but never reach double-digit territory, leaving billions in dry powder chasing marginal opportunities?

It's a real risk. Default forecasts are notoriously unreliable, and the current consensus — mid-single-digit default rates through 2027 — could easily be wrong in either direction. If the Fed pivots to cuts sooner than expected, or if corporations muddle through with asset sales and equity injections, the distressed opportunity set could evaporate quickly.

But LPs are betting on Ares' flexibility. The fund's mandate allows it to pivot into performing credit, structured products, or corporate lending if distressed opportunities dry up. That optionality comes at a cost — it makes the fund harder to benchmark and easier to style-drift — but it also reduces the risk of holding uninvested capital for years.

And here's the thing LPs won't say on the record but acknowledge privately: even if defaults stay muted, dislocations in credit markets can still generate strong returns. Volatility creates opportunity. Rating downgrades force selling. Covenant breaches trigger technical defaults. A fund that can move quickly and write large checks in moments of stress doesn't need a full-blown crisis to hit its return targets.

That's the real thesis behind the $9.8 billion raise. Not that a wave of bankruptcies is coming — though it might be — but that credit markets are repricing, and Ares has the scale, expertise, and LP relationships to capitalize on the dislocations that follow.

The next 18 months will reveal whether Ares timed this raise correctly. If the firm deploys $3-4 billion by mid-2027 at attractive entry points, the fund will likely outperform. If it's still sitting on $7 billion in dry powder two years from now, LPs will start asking harder questions about opportunity cost and fees on uninvested capital.

Watch the sectors Ares prioritizes. If early deployments cluster in real estate and software, that signals the firm sees those markets dislocating first. If energy and industrials dominate, it suggests a different view on where leverage breaks. And if structured credit absorbs more than 20% of the fund in the first year, it means distressed corporate opportunities are scarcer than the fundraising deck implied.

The broader question: is this the beginning of a distressed cycle, or the tail end of a fundraising window that opened prematurely? The answer depends on variables no one controls — Fed policy, corporate earnings, refinancing markets. But Ares just locked in nearly $10 billion to find out. That's either extremely well-timed or a very expensive bet that the world breaks the way the models predict.

Either way, the capital is raised. Now the hard part begins.